Introductions and
Announcements were made by Jennifer Mixel.
Jennifer announced that our meeting was in recognition
of our vendors for their continued support to KEYPOCC.
Presentations
from this meeting can be viewed by:
On a personal note, there
were two new additions to the extended “Keypocc
Family”. Erin Holcombe delivered Paige Erin on
12/9/02, weighing 7lbs 4ozs and Keypocc’s Treasurer,
Beverly McAllister delivered Erin Elizabeth on 01/17/03.
Moms and babies are all doing great!
Cost-effective
Management of Influenza-Like Illness in the
Neuraminidase Inhibitor Era
Wallace
H. Greene, Ph.D.,- Milton S. Hershey Medical
Center
Our first speaker for the
day was Dr. Wallace Green, Ph.D., Assistant Professor of
Pathology and Director of Clinical Virology at the
Hershey Medical Center. Dr. Green spoke on
the Cost-effective Management of Influenza-Like Illness
in the Neuraminidase Inhibitor Era. Dr.
Wallace’s presentation will be made available to all
members on the Keypocc Web page. Some highlights
of Dr. Wallace’s presentation include:
- On average there are
20 million cases of Influenza in the US per year
attributing to a cost of 10 billion dollars a year
to treat.
- Influenza therapy can
be effective if it is given in time.
- Ineffective or late
therapy can attribute to resistant organisms
- Nursing homes have an
influenza rate of 60%
- Diagnosis of Influenza
is based on Clinical judgment, culture, or by
utilizing rapid assays.
- Diagnosis determined
by clinical judgment: 72% of cases were confirmed by
culture, 79% confirmed with RT-PCR.
- Diagnosis determined
by Culture:
- Higher Complexity
testing
- 10-14 days before can
call negative
- Hemadsorption and DFA
confirmation recommended
- Sample handling and
transport plays and important role in culture
sensitivity.
- Decreased accuracy
when sending to Reference Laboratory due to
transport. – Not Recommended
- Diagnosis determined
by Rapid Antigen Detection kits
- Specificity good
during outbreaks
- Sensitivity poor for
some kits
- Several kits and
methodologies were discussed.
- Do not need viable
viruses
- Widely available
- Easy
- Moderate to Waived
complexity
- Subjective read
- After testing is
complete there is no viable isolates for further
characterizations
Back
to top
Management
of Streptococcal Pharyngitis: Role of the
Laboratory and POC Testing
Arthur
E. Crist Jr, Ph.D. - Wellspan Health System,
York Hospital
Our next
speaker was Dr. Arthur E Crist, Jr.,Ph.D., Clinical
Director of Clinical Microbiology at Wellspan Health
System, York Hospital, Department of Laboratories,
Division of Clinical Microbiology. Dr. Crist gave a
presentation on the Management of Streptococcal
Pharyngitis: Role of the Laboratory and POC Testing.
Dr. Crist’s presentation will also be made available on
the Keypocc Web page. Some highlights of Dr.
Crist’s presentation include:
-
It is
important to diagnose and treat streptococcal
phyaryngitis because treatment prevents sequelae.
(Rheumatic Fever, Scarlet Fever, Glomerulonephritits,
Invasive Streptococcal Disease)
-
Sore
throat is caused by Group A streptococcus, S. pyogenes,
Group C S. dysgalactiae, Group G dysgalactiae
-
Clinical
Diagnosis of Streptococcal Pharyngitis:
-
Based on
signs and symptoms
-
Not very
accurate
-
50% of
those treated are not infected with Group A
-
30% of
those not treated will be infected with Group A
-
Laboratory
Diagnosis of Streptococcal Phyaryngitis (culture)
-
Specimen
Collection problems (10% of false negatives can be
attributed to improper specimen collection techniques)
-
Considered
the Gold Standard
-
Selective
vs. Non selective media
-
1 to 2 day
incubation
-
Broth
enhancement
-
Rapid
Antigen Test used in the diagnosis of Streptococcal
Phyaryngitis
-
Methods
extract cell wall antigen from organism on throat swab
-
Extracted
antigen detected by: latex agglutination, enzyme
immunoassay, or optical immunoassay.
-
Many kits
available, 24 are waived.
-
Good
sensitivity and specificity
-
Culture if
rapid antigen results are negativ
-
Molecular
methods (PCR) may equal or exceed sensitivity provided
by culture.
Back
to top
Provider-Performed
Microscopy Testing:
The Wet, the Wild and the
Wiggly
Robert
L. Sautter, Ph.D. - PinnacleHealth System
Our third
speaker for the day was Dr. Robert Sautter, Ph.D., System
Microbiologist and Medical Director, Outpatient
Point-of-Care at Pinnacle Health System. As with our
other 2 speakers, Dr. Sautter’s presentation on Provider
–Performed Microscopy will be available for members to
view on the Keypocc Web page. Highlights of Dr.
Sautter’s presentation include:
-
PPMP is a
CLIA classification
-
Regulated
by CAP, JCAHO, and the PA State Department of Health
-
Examinations
must be performed by a physician, a mid level
practioner or a Dentist.
-
All three
regulating agencies have different requirements for
personnel, physician training, and physician
competency. Differences can also be seen in
procedure requirements, quality improvement programs
and how a POC program verifies the accuracy of the
results for PPMP.
-
At
Pinnacle Health System, the physicians and residents
receive training and yearly competencies.
Support from the laboratories Medical Director is
instrumental in guaranteeing physician cooperation and
compliance.
Back
to top
PPMP
Compliance - One Organization's Approach to a
Complex Issue
Peter
Gawron, B.S. , MT(ASCP) - Milton S. Hershey
Medical Center
Following
lunch, Peter Gawron discussed ways that Hershey Medical
Center had tackled some of their complex issues in
relation to PPMP Compliance. Peter is going to make
his procedures and forms used for this purpose available
to the group via the Keypocc Web page.
During the
Business Meeting the following items were discussed:
Officers for
2003 were announced, they are:
-
President:
Peter Gawron
-
Vice-President:
Jennifer Mixel
-
Treasurer:
Beverly McAllister
-
Secretary:
Wendy Van Dyke
Proposed
changes to the By-laws and Constitution were discussed.
The proposal allowing Corporate Members/Vendors to
serve as officers of the board was approved.
Several Audio
conferences sponsored by Abbott will be available on the
Abbott web site. Role of Troponinis in Diagnosis
Fending and Therapeutic Decision Making, Feb 20 and Feb
27.
March 2003
meeting plans were discussed. Karen Espey and Melody
Botterbusch are the hosts for the meetings. Several
ideas such as PPMP and strep screen testing were
discussed.
Marcy Anderson
discussed that the AACC will be meeting in Philadelphia
this year and there will be a POC Forum. The meeting
will be held on July 24, 2003. Marcy asked that
Keypocc consider “hosting” the meeting. As of
now the format is unknown. She is asking that
Keypocc prepare and present a Storyboard of our
organization for the meeting. A decision was made to
attend the AACC meeting in lei of holding our regular
summer Keypocc meeting. The group also decided that
we would form a subgroup to work on the storyboard.
Chris Fetters
discussed that AACC, POCT division has formed a distance
learning committee. There will be 3 20-minute
PowerPoint presentations available for all to view at no
cost.
The evaluation
of the meeting was extremely positive! With no other
business the meeting was adjourned.
Back
to top
Speakers
Wallace
H. Greene, Ph.D.
Assistant Professor of Pathology and Director of Clinical Virology,
Hershey Medical Center, Pennsylvania State University College of Medicine,
Hershey, Pennsylvania
Wallace
H Greene, Ph.D., is a Diplomate, the American Board of Medical
Microbiology and is Certified in Medical and Public Health Virology. He
was granted a patent in 1989
for a vaccine against infectious bovine keratoconjunctivitis. Dr. Greene
is active in many professional organizations including the American
Society for Microbiology, the Infectious Diseases Society of America, the
Clinical Laboratory Management Association and
the Pennsylvania Strategic Medical Action Response Team. He is also
the current president of the Central Pennsylvania Microbiology
Association.
Arthur
E. Crist, Jr., Ph.D.
Clinical Microbiologist/Technical Director of Clinical Microbiology,
Wellspan Health System, York Hospital, Department of Laboratories,
Division of Clinical Microbiology
Arthur
E. Crist. Jr.,Ph.D., currently serves on the Infection Control Committee
and the Counter-Terrorism Task Force at York Hospital. He is a member of
York Laboratory Associates and the faculty of the School of Medical
technology at York Hospital. Dr.
Crist is a current member of the American Society for Microbiology, the
Anaerobe Society of the Americas and the American Society of Clinical
Pathologists. He has served in the past as both vice president and
president of the Central Pennsylvania Microbiology Association.
Robert
L. Sautter, Ph.D.
System Microbiologist and Medical Director, Outpatient Point-of-Care,
PinnacleHealth System
Robert
L. Sautter, Ph.D., is board-certified by the American Board of Bioanalysis
as a High-Complexity Clinical Laboratory Director. He is a current member
of the American Society for Microbiology, Central Pennsylvania
Microbiology Association and the Consortium of Clinical Microbiologists.
He has served as a past president and vice president for Central
Pennsylvania Microbiology Association. Dr. Sautter is a Clinical Assistant
Professor of Pathology at Penn State University College of Medicine an
adjunct faculty member at Penn State Capital College and Millersville
University and an instructor at Harrisburg Area Community College.
|